Hepatitis C virus (HCV) core protein plays important roles in the pathogeneses of liver steatosis as well as hepatocellular carcinomas due to HCV infection. In this study, we examined de novo fatty acid biosynthesis in hepatic cell line Huh7 cells expressing HCV core protein. The rate of metabolic labeling of cellular fatty acids with [
Hepatitis C virus (HCV) is a major causative agent of chronic hepatitis. 1, 2) Persistent HCV infection, which develops in at least 70 to 80% of infected patients, is strongly correlated with the development of severe liver diseases such as cirrhosis and hepatocellular carcinomas (HCC). 3, 4) In addition, liver steatosis, which involves the accumulation of intracellular neutral lipids as lipid droplets, is a hallmark of chronic HCV infection, 5) and is suggested to play a central role in the progression of the following liver cirrhosis and HCC in chronic hepatitis C patients. 6) Since more than 170 million people in the world are currently infected with HCV, 1) understanding the mechanisms by which HCV induces serious liver diseases is one of the most important global public health issues.
HCV, belonging to the Flaviviridae family, possesses a linear, positive-stranded RNA genome of ca. 9600 nucleotides. 7) The HCV genome has a single open reading frame encoding a precursor polyprotein of ca. 3000 amino acids that is processed into at least 10 individual proteins by host and viral proteases. 8) HCV core protein, the product of the N-terminal portion of the polyprotein, forms the nucleocapsid of an HCV virion. 9) Besides its function as a viral structural protein, the core protein causes intracellular lipid accumulation as well as malignant transformation in cultured cells. [10] [11] [12] [13] Moreover, transgenic mice expressing HCV core protein developed liver steatosis and the following HCC. 14, 15) These results strongly suggest that HCV core protein is involved in the pathogeneses of liver diseases including steatosis due to HCV infection.
The details of the mechanisms by which HCV core protein causes intracellular neutral lipid accumulation are not well understood. Extensive screening for genes/proteins exhibiting differences in cellular expression involving cDNA microarray or proteome analysis has been performed for HCV core-expressing cultured liver cells or transgenic mice. [16] [17] [18] [19] Although various genes/proteins were identified, direct information on the genes/proteins related to lipid metabolism altered by HCV core protein expression has not been obtained yet. Since HCV core protein is distributed mainly in lipid droplets of host cells, 10, 13, [20] [21] [22] [23] the biogenesis and/or functions of lipid droplets might be affected by the core protein.
As reported, the core protein appears to inhibit microsomal triglyceride transfer protein activity in the livers of HCV core-transgenic mice, thus interfering with the hepatic assembly and secretion of apo-B-carrying very low density lipoproteins. 24) As a result, triglycerides appear to accumulate within hepatocytes, steatosis developing. HCV core protein also interacts with apoA2, a major component of highdensity lipoproteins, in cells. 10, 25) These results should be important regarding the pathogenesis of HCV core-derived steatosis, but may not explain all the functions of the core protein causing intracellular neutral lipid accumulation. In this study, we investigated de novo fatty acid biosynthesis, which can significantly affect intracellular lipid metabolism, especially neutral lipid accumulation, 26, 27) in HCV core-expressing liver cells. We found elevated fatty acid biosynthesis, and higher expression and activities of the enzymes responsible for de novo fatty acid biosynthesis in HCV coreexpressing cells.
MATERIALS AND METHODS

Cell Lines
The human hepatic Huh7 cell line constitutively expressing HCV core protein (Uc39-6) was established by transfection with pcEF39neo. 28) Expression level of HCV core protein in Uc39-6 cells was similar to that in core-expressing Hep39 cells (data not shown), which we established previously. 28, 29) Another Huh7 cell line transfected with ex- pression vector pcEF321swxneo 28) without the HCV core protein insert (Uc321) was used as a mock control. Both cell lines were plated on collagen-coated dishes (Asahi Techno Glass, Japan) and maintained in normal culture medium (DMEM supplemented with 10% fetal bovine serum, 100 units/ml penicillin G, 100 mg/ml streptomycin sulfate, and 1 mg/ml G418 (Sigma, U.S.A.)) under a 5% CO 2 atmosphere at 37°C. Growth rates under the culture condition we used were comparable between Uc321 and Uc39-6 cells.
Enhancement of de Novo Fatty Acid Biosynthesis in Hepatic Cell Line Huh7 Expressing Hepatitis C Virus Core Protein
Metabolic Labeling of Cellular Lipids Subconfluent cell monolayers in 6-cm dishes were incubated in 2 ml of the normal medium containing 1.3 mM [ 3 H]acetate (Moravek Biochemicals, U.S.A.) for various times. After being washed three times with 3 ml of PBS, the cells were lysed in 1 ml of 0.1% SDS at 4°C, and then 100 and 800 ml aliquots of the resultant cell lysate were used for protein determination and lipid extraction, respectively. Cellular lipids were extracted into the organic solvent 30) and dried up. To determine the total metabolic incorporation of [ 3 H]acetate into the fatty acid moieties of lipids, the extracted lipids were treated with 90% ethanol containing 1 N KOH for 1 h at 70°C and then re-extracted with petroleum ether. Fatty acids were then separated on TLC plates with a solvent system of hexane/diethylether/acetate (70/30/1, vol/vol). The radioactivity of fatty acids was determined with a BAS1800 imaging analysis system (Fuji Film, Japan). The values were normalized as to cell protein.
In Vitro Acetyl-CoA Carboxylase (ACC) and Fatty Acid Synthase (FAS) Activity Assays ACC activity assays were performed using [ . 32) Cytosolic fractions, which contain ACC1 and FAS, were prepared as below. After being washed with PBS, cells were harvested and precipitated by centrifugation (300ϫg, 5 min). The precipitated cells were resuspended in 125 mM potassium phosphate, pH 7.0, and then lysed by sonication. After centrifugation of each lysate at 2500ϫg for 5 min, the cytosolic fraction (supernatant) was separated from the post-nuclear supernatant by centrifugation at 100000ϫg for 60 min. The protein concentrations of the preparations were determined with a BCA protein assay kit (Pierce, U.S.A.).
Immunoblot Analysis Equivalent amounts of proteins from Uc321 and Uc39-6 cells were separated in a 4-12% SDS-polyacrylamide gel and then electrophoretically transferred to polyvinylidene difluoride membranes. The membranes were blocked overnight at 4°C in TBS containing 0.1% Tween 20 and 5% skim milk. The blots were probed with a rabbit polyclonal anti-ACC1 antibody (Upstate, U.S.A.) (1 : 1000), a mouse monoclonal anti-FAS antibody (BD Transduction Laboratories, U.S.A.) (1 : 1000), and a mouse monoclonal anti-HCV core protein antibody (Anogen, Canada) (1 : 2000) for 90 min at room temperature. The blots were then incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (BIO-RAD, U.S.A.), or HRP-conjugated goat anti-mouse IgG (GE Healthcare, U.S.A.) at 1 : 2000 dilution for 60 min. Detection of immunoreactive proteins was performed with an ECL system (GE Healthcare, U.S.A.).
Quantitative Real-Time PCR Analysis Cellular total RNAs were prepared with an RNeasy kit (Qiagen, U.S.A.). The total RNA fraction (1 mg) was processed directly to cDNA using a Transcriptor First Strand cDNA Synthesis Kit (Roche, U.S.A.). Of the total 20 ml cDNA solution, an aliquot of 0.5 ml was used for each real-time PCR assay. The PCR primers used for human ACC1 were: forward, CTGTTGGC-TCAGATACACTC, and reverse, GCCACAGTGAAATCTC-GTT. The PCR primers for human FAS were: forward, GTG-GGAAGGTGTACCAGTG, and reverse, AGGATGCCCTG-GAAATGAG. Quantitative real-time PCR was carried out in a LightCycler (Roche, U.S.A.) using LightCycler-FastStart DNA Master SYBR Green I (Roche, U.S.A.). Specific PCR products amplified against individual genes were used as quantitative standards.
RESULTS
To determine the effect of HCV core protein expression on cellular fatty acid biosynthesis, we established Uc39-6 cells, a human hepatic Huh7 cell line transfected with the pcEF321 mammalian expression vector containing the HCV core protein gene, and Uc321 cells, a control Huh7 cell line transfected with the pcEF321 vector without the core protein gene. Consistent with previous studies involving HCV coreexpressing hepatic cell lines, 10, 33) HCV core protein was preferentially distributed in the endoplasmic reticulum and lipid droplets in Uc39-6 cells, as determined on immunofluorescence microscopy (data not shown H]fatty acids formed) in these cells. Incorporation of radioactivity into the fatty acid moieties of complex lipids was ca. 1.5-fold higher in HCV core-expressing Uc39-6 cells than that in non-expressing Uc321 cells during the incubation time at 37°C (Fig. 1) . Similar results were obtained with other Huh7 cell lines expressing HCV core protein (data not shown), ruling out the possibility that the increase in radiolabeled fatty acids in HCV core-expressing cells are due to the peculiar cell clones. These results indicate that the rate of de novo biosynthesis of cellular fatty acids is enhanced in HCV core-expressing cells. Fatty acid biosynthesis is carried out by cytosolic enzymes, i.e., ACC1 and FAS. 34) We assayed these enzyme activities in cytosolic fractions of Uc321 and Uc39-6 cells. HCV core-expressing Uc39-6 cells showed a ca.1.6-fold higher level of ACC activity than Uc321 cells (Fig. 2A) . The cytosolic FAS activity in Uc39-6 cells was slightly higher than that in Uc321 cells (Fig. 2B ). These results demonstrate that the enzymatic activities responsible for fatty acid biosynthesis, especially ACC activity, are elevated in HCV core-expressing Uc39-6 cells, consistent with the results of metabolic labeling experiments involving [ 3 H]acetate. Cytosolic ACC and FAS activities are attributed to ACC1 and FAS molecules, respectively. 34) We next performed immunoblot analyses of ACC1 and FAS molecules in lysates of Uc321 and Uc39-6 cells. Uc39-6 cells contained a ca. 2-fold higher amount of ACC1 protein than Uc321 cells (Fig. 3) , whereas the protein level of FAS in UC39-6 cells was comparable to that in Uc321 cells. These results suggest that the elevated protein level of ACC1, a rate-limiting enzyme for fatty acid biosynthesis, may contribute to the higher ACC activity, leading to enhanced fatty acid biosynthesis, in HCV core-expressing Uc39-6 cells. We also determined the mRNA levels of ACC1 and FAS in Uc321 and Uc39-6 cells by quantitative real-time PCR. Consistent with the protein levels of ACC1, the ACC1 mRNA content in Uc39-6 cells was significantly higher than that in Uc321 cells (Fig. 4A) . The FAS mRNA content in Uc39-6 cells was also higher than that in Uc321 cells (Fig. 4B) . These results suggest that elevated expression of the ACC1 (and FAS) gene(s) causes a higher rate of de novo fatty acid biosynthesis in HCV coreexpressing cells.
DISCUSSION
In this study we showed that the rate of de novo fatty acid biosynthesis was elevated in HCV core-expressing cells (Fig.  1) . We also demonstrated that the protein and mRNA expression levels as well as the in vitro enzymatic activity of ACC1, which is a rate-limiting key enzyme for fatty acid biosynthesis, were significantly enhanced in HCV core-expressing Uc39-6 cells (Figs. 2-4) . These results strongly suggest that the higher expression of ACC1 contributes to the increased fatty acid biosynthesis in HCV core-expressing cells.
Many studies have demonstrated that HCV core protein substantially affects various cellular regulatory processes including gene transcription. [35] [36] [37] These biological activities of HCV core protein might be involved in the mechanism by which HCV core protein enhances expression of the ACC1 gene.
HCV core protein is localized mainly in lipid droplets of host cells, 10, 13, [20] [21] [22] [23] and a small portion of ACC1 molecules is also associated with lipid droplets. 38) It is well known that the activity of ACC1 can be regulated posttranslationally through its phosphorylation, and allosteric effectors such as citrate and fatty acids. 39 ) Thus, we can not exclude the possibility that HCV core protein activates ACC1 directly in lipid droplets, although we have not examined this yet.
We also found that the FAS mRNA expression level was slightly enhanced, but the protein level as well as the in vitro enzymatic activity of FAS were not significantly elevated in Uc39-6 cells (Figs. 2-4 ). FAS appears to make a lesser contribution to the enhancement of fatty acid biosynthesis in Uc39-6 cells under our culture conditions, although further investigations are needed.
We think that our findings may provide a new insight into the metabolic pathways for lipids by which HCV core protein causes steatosis, one of the characteristic indications of chronic hepatitis C infection. Although in the future we have to determine whether or not our in vitro findings are applicable to an in vivo situation on HCV infection, inhibition of ACC1 and/or FAS activity might be effective for preventing the liver steatosis due to HCV infection. Grants-in-Aid from the Ministry of Health, Labor and Welfare; the program for the Promotion of Fundamental Studies in Health Sciences of the Organization for Drug ADR Relief, R&D Promotion, and Product Review of Japan; the Takeda Science Foundation; and the Viral Hepatitis Research Foundation of Japan.
